Clinical Trial Update: A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

View source ↗

Summary

A multi-center registry sponsored by Tempus AI aims to discover molecular biomarkers across hematologic malignancies, including acute myeloid leukemia and folli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Follicular Lymphoma

Snippet

Sponsor: Tempus AI | Conditions: Acute Myeloid Leukaemia (AML), Follicular Lymphoma ( FL) | Status: RECRUITING